Abstract
Introduction
Ž . Free fatty acids FFA are the preferred energy substrate w x utilized by heart muscle 1 . However, the heart has a limited potential to synthesize FFA. Hence, FFA are supplied to cardiac cells from several sources: through lipoly-Ž . sis of endogenous cardiac triglyceride TG or from exoge-Ž nous sources in the blood as free acid bound to albumin . or as TG in lipoproteins . Vascular endothelial-bound Ž . lipoprotein lipase LPL catalyzes the breakdown of the Ž TG component of lipoproteins very-low-density lipopro-. tein or VLDL and chylomicron , and partially regulates FFA supply to the tissues. Hence, it is also called 'funcw x tional' LPL 2 . As endothelial cells cannot produce LPL, w x it is synthesized and processed in myocytes 3 , and then Ž . translocated onto heparan sulfate proteoglycan HSPGs ) Corresponding author. Tel. q1 604 822-4758; Fax q1 604 822-3035.
binding sites on the vascular surface where it actively w x metabolizes lipoproteins 4 .
Functional LPL is the rate-limiting enzyme in TG clearance; hence, a reduction in LPL activity is often associated with parallel changes in the catabolism of TG-rich lipoproteins, and in the supply of FFA to the heart. Thus, perfused hearts from insulin-deficient diabetic rats have been charw x acterized as having a lowered functional LPL activity 5 with a corresponding reduction in the ability to degrade w x TG-rich lipoproteins 6 . LPL activity is decreased in skeletal muscle and adipose tissue in hypertensive patients w x w x 7,8 and Dahl salt-sensitive hypertensive rats 9 . However, no information is available on the regulation of cardiac LPL during hypertension. Hence, the objectives of the present study were to determine functional, heparin-re-Ž . leasable from perfused whole heart and cell-associated Ž . from isolated cardiomyocytes cardiac LPL activity during the development of hypertension in spontaneously Ž . hypertensive SHR rats.
Methods

Experimental animals
All animals in the study were cared for in accordance with the principles promulgated by the Canadian Council on Animal Care and The University of British Columbia.
Ž . Male SHR and Wistar Kyoto WKY rats were obtained at Ž . 6 weeks of age Charles River, Montreal, Que. . The rats Ž . were maintained under a 12 h light 07:00-19:00 -dark cycle. Rats were housed 2-3 per cage and supplied with a Ž standard laboratory chow diet Lab Diet a5001, PMI . Feeds, Richmond, VA and water ad libitum. As blood pressure is significantly higher only after 9-10 weeks of age in SHR rats, WKY and SHR rats were killed before Ž . 7-8 weeks of age and after the development of severe Ž . hypertension 15-16 weeks of age , and LPL activity determined.
Measurement of blood pressure
Measurements of systolic blood pressure were done in conscious rats by the indirect tail cuff method without w x external pre-heating 10 . Animals were placed in a rat Ž holder in a chamber Model 306, IITC Inc., Woodland . Hills, CA maintained at 298C. The tail cuff with pressure sensor was attached to the base of the tail and connected to Ž . a cuff pump Model 20-NW, IITC Inc. . A semiautomatic Ž BP analyzer and an analog-to-digital recorder Model 179, . IITC Inc. are connected to the tail cuff to amplify and record the signal from the pressure sensor. With this Ž method, the reappearance of pulsations on gradual defla-. tion of the cuff is detected by the photoelectric sensor. Three readings out of 5 are averaged to determine BP.
Animals were always preconditioned to the experimental procedure before conducting the actual measurements. Our Ž . readings are similar within 5 mmHg to those obtained by w x direct cannulation 11 .
Isolated whole heart perfusion
Rats were anesthetized with 50 mgrkg sodium pento-Ž . barbital i.p. MTC Pharmaceuticals, Cambridge, Ont. , the thoracic cavity opened and hearts removed. Rats were not injected with heparin prior to killing, as it displaces LPL bound to HSPGs on the capillary endothelium. Consequently, it was necessary to remove and cannulate the heart as quickly as possible to avoid clotting of blood in the coronary arteries. Immediately upon excision, the beat-Ž . ing heart was immersed in cold 48C calcium-free Joklik Ž . minimal essential medium pH 7.4 supplemented with 2 g NaHCO , 1.2 mM MgSO , and 1 mM L-carnitine. After 3 4 cannulation of the aorta, the hearts were perfused retrogradely by the non-recirculating Langendorff technique for Ž . w x 5 min or until the perfusate was clear of blood 12 . This period is necessary to remove proteases released by tissue damaged during the dissection that would reduce LPL activity subsequently measured in the hydrolysis assay. The perfusion fluid was continuously gassed with 95% O r5% CO in a double-walled water-heated chamber 2 2 that was kept at 378C with a temperature-controlled circu-Ž . lating water bath. The rate of coronary flow 7-8 mlrmin w Ž was controlled by a Masterflex Cole Parmer Instrument . Co., Chicago, IL pump. To measure the release of LPL activity into the medium, the perfusion solution was Ž changed to Joklik containing 1% BSA wrv, 0.15 mM, . Fraction V, Boehringer Mannheim, Germany , 1 mM CaCl 2 Ž .w x and heparin 5 Urml 13 . This concentration of heparin was previously shown to maximally release cardiac LPL w x from its binding sites 14 . The coronary effluent was collected in timed fractions and frozen until assayed for LPL activity. Ž . Hence, nifedipine 3 mgrkg in 40% ethanol was injected into the tail veins of 15-16-week-old SHR rats. Thirty minutes following nifedipine injection, the rats were killed, hearts removed and perfused with heparin, and the perfusate collected and analyzed for LPL activity. In another experiment, hearts from 15-16-week-old SHR and WKY rats were perfused in vitro with recirculating Joklik buffer Ž . containing nifedipine 100 nM for 10 min. This was followed by perfusion with heparin, and fractions of perfusate were collected and analyzed for LPL activity. CGS-21680, an A -purinergic receptor agonist, has also been 2 shown to dilate coronary blood vessels with insignificant w x effects on cardiac function 19 . Hence hearts from hyper-Ž . tensive SHR 15-16 weeks rats were similarly perfused Ž . with 10 mM CGS-21680 RBI, MA, USA for 10 min followed by a 10 min perfusion with heparin to release endothelium-bound LPL. During perfusion with nifedipine or CGS-21680, the coronary flow rate was kept constant at 7-8 mlrmin.
Preparation of cardiac myocytes
Perfusion of the heart with heparin predominantly releases extracellular, endothelial-bound LPL. However, Ž . heparin non-releasable cellular LPL activity can still be measured in the myocytes. To measure this fraction, cal-Ž . cium-tolerant myocytes were made from hearts ventricles w x by a previously described procedure 14 . Briefly, hearts were removed from anesthetized rats and digested by Ž . perfusing collagenase 228 Urml retrogradely through the heart. Myocytes were made calcium-tolerant by successive exposure to increasing concentrations of calcium. Our method of isolation yields a highly enriched population of calcium-tolerant myocardial cells that are rod-shaped in the presence of 1 mM Ca 2q with clear cross-striations. Intolerant cells are intact, but hypercontract into vesicu-Ž . lated spheres. Yield of myocytes cell number was determined microscopically using a Neubauer hemocytometer.
Ž . Myocyte viability generally between 75 and 85% was assessed as the percentage of elongated cells with clear cross striations that excluded 0.2% trypan blue.
Cardiac myocytes from WKY and SHR rats were suspended in Joklik-minimum essential medium to a cell density of 0.4 = 10 6 cellsrml and incubated at 378C under an atmosphere of 95% O r5% CO . To release surface- 2 2 Ž . bound LPL activity, heparin 5 Urml was added to the Ž . myocyte suspension. Aliquots of cell suspension 1 ml were removed at specified intervals, and the medium was Ž . separated from cells by centrifugation 3000 = g for 10 s in an Eppendorf microcentrifuge. The supernatant was Ž . decanted and stored y708C with corresponding cell pellets until assayed for LPL activity.
LPL assay
LPL catalytic activity in coronary perfusates and incubation medium of cardiac myocytes was determined by w 3 x measuring the in vitro hydrolysis of a sonicated H triolein substrate emulsion. The standard assay conditions w 3 x Ž were 0.6 mM glycerol tri 9,10-H oleate 1 mCirmmol; 1 . Ž . Ž . Ci s 37 GBq , 25 mM PIPES pH 7.5 , 0.05% wrv Ž . albumin, 50 mM MgCl , 2% vrv heat-inactivated 2 Ž chicken serum containing the LPL activator, apolipo- Ž . perfused hearts from WKY and SHR rats at 7-8 A , 11-12 B and Ž . 15-16 C weeks of age. Rats were perfused with Joklik MEM as Ž described in Methods. At the time indicated by the arrow, heparin 5
. Urml was added to the buffer, and LPL activity measured in the coronary perfusate which was collected for 10 s at the indicated times. The insets represent area under the curve for heparin-releasable LPL activity in perfused hearts from WKY and SHR rats. Results are the mean"s.e.m. from the number of experiments indicated in parentheses. Changes in LPL activity in response to heparin, over time, were analyzed by multivariate analysis of variance followed by the Neumann-Keuls test; ) P -0.05 relative to WKY. protein CII , plus 100 ml of either myocyte medium or heart perfusate in a total volume of 400 ml. The release of w 3 x H oleate was measured after incubation for 30 min at w 3 x 308C. The presence of hydrolyzed H oleate in the medium was determined by adding 3 ml of fatty acid extraction w x solution and 100 ml of 0.1 M NaOH 20 . After vortex mixing and centrifugation, the radioactive sodium w 3 x Ž . H oleate in a sample 0.5 ml of the upper phase was determined by liquid scintillation counting. All LPL assays were performed in duplicate where the reaction rate was linear with respect to time and volume of medium assayed. The validity of the LPL assay has been previously estabw x lished 20 . Results are expressed as nanomoles oleate Ž .
6 released per hour per ml coronary perfusate or 10 cells Ž . myocyte medium or cells .
Heparin non-releasable cellular LPL activity was mea-
. Ž . 8.0 containing 0.125% vrv Triton X-100. After sonication, the volume was adjusted to 1 ml using sucrose buffer Ž0.25 M sucrose, 1 mM EDTA, 1 mM dithiothreitol, 10
. w x mM HEPES, pH 7.4 21 . The assay for cell sonicate LPL activity was done essentially as described above except Ž . that 20 ml of cell sonicates was used and heparin 2 Urml was added.
Plasma measurements
Ž
. After a 5-h fasting period 09:00-14:00 h , blood samples from the tail vein were collected in heparinized glass capillary tubes. Blood samples were immediately cen-Ž . trifuged 3246 = g for 10 min at 48C and plasma was Ž .
Ž . Fig. 2 . Effect of hypertension on LPL activity in cardiac myocytes from SHR and WKY rats at 7-8 A and 15-16 B weeks of age. Myocytes were prepared as described in Methods. LPL activity in cell homogenates was determined at time 0 by removing a sample of cell suspension followed by Ž . Ž . centrifugation, homogenizing of the cell pellet and determination of cellular LPL activity left panel . Heparin 5 Urml was then added to the incubation medium at the time indicated by the arrow and the release of LPL activity into the incubation medium determined at the indicated times of incubation Ž . right panel . Results are the mean"s.e.m. from the number of experiments indicated in parentheses. Probability values were calculated by a Student's t-test; ) P -0.05 relative to WKY for cellular activity at 15-16 weeks. 
. Que. . Plasma insulin was measured using rat insulin Ž . standards Novo, Copenhagen, Denmark . This radioimmunoassay method allows for measurement of small sample volumes of 25 ml, with an interassay and intra-assay coefficient of variation of less than 15% and a sensitivity w x to 10 mUrml 22 . 
Materials
Joklik minimal essential medium was obtained from Ž .w 3 x Gibco Canada Burlington
Statistical analysis
All data are reported as mean " s.e.m. unless otherwise stated. Unpaired Student's t-test was used to determine differences between group means. Changes in whole heart LPL activity over time in response to heparin was ana-Ž . lyzed by multivariate analysis of variance ANOVA followed by the Neumann-Keuls test using the Number Ž w Cruncher Statistical System Program NCSS , Kaysville, . UT . The level of statistical significance was set at P -0.05. Table 1 shows the chronological changes in general characteristics and plasma parameters of the animals. There were no marked differences in body weight until week 15, at which point body weight in WKY rats was significantly greater than SHR. At 7-8 weeks, blood pressure of SHR rats was not significantly different from WKY controls. However, SHR blood pressure gradually increased over time reaching ; 200 mmHg at 15-16 weeks of age. At this age, the blood pressure was 74 mmHg higher in SHR relative to WKY rats. We did not observe any difference in heart weightrbody weight ratio between WKY and SHR Ž rats at 15-16 weeks of age WKY 3.6 " 0.21; SHR 3.7 " . 0.24, mgrg .
Results
General characteristics and plasma parameters
All plasma parameters were measured after a 5 h fast Ž . 09:00-14:00 h . There was no significant difference in plasma glucose or insulin between WKY and SHR rats at all ages studied. Plasma TG and total cholesterol were significantly lower in SHR rats than in WKY animals at 7-8 and 15-16 weeks. However, plasma FFA concentrations in 15-16-week-old SHR rats were elevated when compared to age matched WKY controls.
Coronary endothelial LPL
Retrograde perfusion of the isolated whole heart with heparin resulted in a release of LPL into the coronary Ž . perfusate Fig. 1 . The heparin-induced LPL discharge was rapid, and peak activity, suggested to represent LPL located at or near the endothelial cell surface, was observed within 1.5-2 min. On continuous perfusion with heparin, there was a progressive decline in LPL activity to values close to baseline. At 7-8 weeks, heparin-releasable LPL activity in SHR rat hearts was comparable to values ob-Ž . tained from WKY animals Fig. 1A , inset . However, with increasing age and blood pressure, a decline in peak and total heparin-releasable LPL activity was observed in SHR Ž . rats relative to WKY animals Fig. 1B and 1C, insets . 
Cardiac myocyte LPL
LPL is synthesized in cardiac myocytes, and then translocated to the coronary endothelium where it hydrolyzes circulating lipoprotein-TG. To determine whether the decline in cardiac heparin-releasable LPL activity in SHR rats is a consequence of alterations at the site of synthesis, cardiac myocytes from SHR and WKY rats were isolated Ž . recirculating Joklik buffer containing nifedipine 100 nM for 10 min. This was followed by perfusion with heparin, with fractions of perfusate collected and analyzed for LPL activity as described previously. For the Ž . in vivo study, nifedipine 3 mgrkg was injected through the tail vein. 30 min following nifedipine injection, the rats were killed, the hearts removed and perfused with heparin and the perfusate collected and analyzed for LPL activity. Results are the mean"s.e.m. from the number of experiments indicated in parentheses; ) P -0.05 relative to untreated SHR.
at different ages and LPL activity in cell sonicates mea-Ž sured. There was no difference in myocyte viability % . Ž live cells between the WKY and SHR rats at 7-8 WKY . Ž . 79 " 3; SHR 81 " 1 or 15-16 WKY 83 " 1; SHR 81 " 2 Ž weeks of age. Similarly, myocyte yield total number of 6 . Ž . cells = 10 at 7-8 WKY 11 " 1.5; SHR 9.2 " 0.6 or Ž . 15-16 WKY 9.3 " 1; SHR 8.8 " 0.9 weeks of age was similar in WKY and SHR rats. No difference in total cellular LPL activity was observed in SHR and WKY rats Ž . at 7-8 weeks of age Fig. 2A , left panel . However, at 15-16 weeks, SHR rats had higher total cellular LPL Ž . activity when compared to WKY rats Fig. 2B , left panel . The increase in cellular LPL activity was not accompanied by a parallel rise in the secretion of enzyme. At both 7-8 Ž . Ž Fig. 2A, right panel and 15-16 weeks Fig. 2B, right . panel of age, there was no difference in heparin-induced release of LPL from cardiac myocytes isolated from SHR and WKY rats.
Insulin and LPL actiÕity
. Based on reports that a insulin can release LPL from its binding sites on cultured 3T3-L1 adipocyte cell surface w x . 23 , and b the presence of hyperinsulinemia in SHR rats w x 24,25 , we hypothesized that the decrease in endothelial LPL activity in SHR rats could be a result of elevated insulin levels in these animals. However, our current results indicate that 5-h fasted plasma insulin levels in SHR and WKY rats were similar at all time points measured Ž . Table 1 . Moreover, retrograde perfusion of isolated rat hearts from 15-16-week-old WKY and SHR rats with insulin failed to release LPL activity into the coronary Ž . perfusate Fig. 3 . 
Acute effects of Õasodilators
Nifedipine treatment in vivo effectively reduced the Ž blood pressure of 15-16-week-old SHR rats 108 " 6 . Ž mmHg as compared to pre-treatment values 199 " 9 . mmHg within 30 min. This effect lasted over 2 h, at which point blood pressure returned to pre-treatment values. Nifedipine had no effect on the blood pressure of Ž . 15-16-week-old WKY rats. Fig. 4 A,B demonstrates the effects of nifedipine on heparin-releasable LPL activity in Fig. 5 . Effect of in vitro treatment with CGS-21680 on heparin-releasable LPL activity in perfused hearts from SHR rats at 15-16 weeks of age. Hearts were perfused for 10 min with 10 mM CGS-21680 in Joklik buffer followed by heparin perfusion. The fractions were collected at the indicated times and LPL activity measured. Results are the mean"s.e.m.; ) P -0.05 relative to untreated SHR. Fig. 4A . However, nifedipine administered either in vitro for 10 min or in vivo for 30 min prior to removal of the heart increased peak heparin-releasable LPL activity in SHR rat hearts Ž . Fig. 4B . A similar increase in heparin-releasable LPL activity was observed in 15-16-week-old SHR rat hearts on prior perfusion for 10 min with CGS-21680 in vitro Ž . Fig. 5 . In vivo treatment of SHR rats with CGS-21680 could not be performed due to its extremely short duration of action. Nifedipine and CGS-21680 by themselves had no effect in releasing cardiac endothelial LPL.
Discussion
During hypertension, LPL activity is decreased in skelew x tal muscle and adipose tissue in human patients 7,8 and w x Dahl salt-sensitive hypertensive rats 9 . We questioned whether a similar reduction in LPL activity exists in the hypertensive SHR rat heart. To this end, we measured the rapid, heparin-releasable LPL fraction in whole hearts obtained from WKY and SHR rats. This rapidly releasable Ž fraction is more sensitive to altered physiological e.g., . Ž feeding, fasting and pathological e.g., diabetes, hyper-. thyroidism states than total tissue activity. More importantly, the ability of the heart to hydrolyze lipoprotein-TG is closely linked to changes in the rapidly releasable LPL, w x but not to the remaining cellular fraction 2 . Hence, any change in cardiac LPL activity during hypertension may have significant implications in altering the supply of FFA to the heart. In this report, we show for the first time that coronary heparin-releasable LPL activity is decreased in 15-16-week-old SHR rat hearts when compared to agematched WKY animals, and propose that this phenomenon could be intrinsic to the hypertensive state per se.
Insulin has been cited as an important factor affecting LPL activity in vivo. For example, in normal-weight subjects, hyperinsulinemia combined with insulin resistance was associated with a reduced LPL activity in skeletal w x w x muscle 7 and post-heparin plasma 26 . In addition, w x Marotta et al. 8 recently observed a strong correlation between serum insulin and post-heparin plasma LPL activity in mild hypertensive patients. Since SHR rats have w x been characterized as hyperinsulinemic 24,25 , we considered the possibility that the reduced heparin-releasable LPL activity in SHR rat hearts was secondary to high insulin levels. However, we found that insulin levels in the SHR rats were not significantly elevated when compared to WKY rats of the same age. Similarly, other studies have reported no evidence of hyperinsulinemia in SHR rats w x relative to WKY animals 27-29 . The contradictory findings in the literature with regard to the state of insulinemia in SHR animals could be explained by differences such as Ž the age group studied and procurement of animals WKY rats may be endocrinologically non-homogenous dependw x. ing on the commercial source 30 . Insulin was previously reported to directly release LPL from its binding sites on w x 3T3-L1 adipocytes 23 , an effect suggested to involve the liberation of LPL via the phospholipase-C-catalyzed hydrolysis of a glycosylphosphatidylinositol membrane anchor. However, in this study, insulin did not displace endothelial-bound LPL into the coronary perfusates. Similarly, LPL was not released by insulin from isolated conw x trol and diabetic myocytes 31 or by phosphatidylinositolspecific phospholipase C from bovine aortic endothelial w x cells 32 . Moreover, it was recently reported that LPL did not possess a glycosylphosphatidylinositol membrane anw x chor 33 . Thus, it appears that neither a direct effect of insulin nor the presence of a hyperinsulinemic state could account for the lowered heparin-releasable cardiac LPL activity in SHR rats. As the LPL gene has been located w x exclusively in cardiomyocytes 34 , we further postulated that the reduced heparin-releasable enzyme activity may be due to decreased cellular LPL content or secretion. However, both cellular and secreted LPL activities in this study do not indicate a diminished LPL synthesis in SHR rat myocytes.
As reduction in enzyme activity paralleled the progressive development of hypertension, the lower heparin-releasable LPL activity in SHR rat hearts could be related to the hypertensive state per se. A positive correlation between plasma LPL activity and aortic flow velocity has been reported in mild, uncomplicated hypertensive patients w x 8 . Factors such as poor peripheral blood flow, vascular hypertrophy and rarefaction of blood vessels have been proposed to affect LPL action during hypertension by reducing vascular surface area for enzyme binding sites w x andror impeding the delivery of substrate 35 . We examined whether the increased perfusion of coronary vasculature could enhance the heparin-releasable LPL activity in hypertensive animals. Interestingly, both nifedipine and CGS-21680, vasodilators with divergent mechanisms of action, normalized heparin-induced LPL release, suggesting that flow through coronary blood vessels may regulate LPL activity. In support of these findings, the reduced clearance of a circulating chylomicron-like emulsion in Ž . SHR rats was improved with doxazosin an a -blocker 1 w x 36 , whereas a 4-fold increase in post-heparin plasma LPL activity was observed in obese Zucker rats following treatq w x ment with the K -channel opener, AL0671 37 , a potent vasodilator.
SHR rats have previously been reported to be hyperw x triglyceridemic 24,38 , a finding clearly opposite to that obtained in the present study. The discrepancy in plasma TG between this and previous studies occurred despite Ž identical experimental parameters i.e., the age of animals, . and duration and time of fasting . Reduced levels of serum TG and cholesterol in SHR rats relative to normotensive w x Wistar or WKY rats have similarly been reported 39,40 . The reasons for hypotriglyceridemia in SHR rats are presently unclear. Plasma TG levels generally represent a Ž . balance between production from the liver and gut and Ž . removal lipolysis of TG-rich lipoproteins . As vasoconw x striction appears to restrict LPL action in SHR rats 41 , the apparently low TG in SHR rats may be the result of a reduced production of lipoprotein-TG.
In conclusion, our results suggest that hypertension per se may regulate heparin-releasable LPL activity in the SHR rat heart. Although the approximate contribution of Ž different sources of FFA from the circulation or intra-. cellular sources towards b-oxidation in the SHR rat heart is not known, the reduced cardiac LPL action, coupled with low circulating TG levels, could significantly diminish FFA supply to the heart via the exogenous pathway. Interestingly, fuel use in the SHR heart was found to be shifted from FFA towards glucose, a biochemical adaptation thought to promote energetic economy amidst adverse w x hemodynamic conditions 42 . In light of this observation, the focus of ongoing studies is to determine the impact of a reduced heparin-releasable LPL activity on FFA supply and utilization in the hypertensive rat heart.
